MAP3K2 and cancer: In addition, studies have confirmed that miR-186 inhibited the metastasis of bladder cancer by targeting NSBP1,25 breast cancer by targeting Twist1,26 and non-small cell lung cancer by targeting MAP3K2,27 playing an important role in the metastasis of multiple cancers.